HWY-336

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHWY-336
Drug Alias NameMAP kinase inhibitor (Hanwha)HWY-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsInflammationNeoplasmsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanwha Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanwha Chemical
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasmsMycoses

Other Information

ATC CodeN/A
Related LinksN/A